- Trials with a EudraCT protocol (3)
 - Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
 
		
	   		
	   		    
                    
                   	
                   	    3 result(s) found for: Particle-size distribution.
                    
                
			
   			
		
		Displaying page 1 of 1.
	
	
| EudraCT Number: 2011-005544-10 | Sponsor Protocol Number: NIHRCDF | Start Date*: 2012-04-10 | |||||||||||
| Sponsor Name:Imperial College London | |||||||||||||
| Full Title: Improving Inhaler Treatment and Small Airways Assessment in Chronic Obstructive Pulmonary Disease | |||||||||||||
| Medical condition: Chronic Obstructive Pulmonary Disease (COPD) | |||||||||||||
					
						
							
  | 
			|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2014-001089-90 | Sponsor Protocol Number: OTT329/402 | Start Date*: Information not available in EudraCT | ||||||||||||||||
| Sponsor Name:Oriel Therapeutics, a Sandoz Company | ||||||||||||||||||
| Full Title: Study to Test the Product Robustness of a Dry Powder Inhalation Device When Used in Normal Clinical Practice with Young Asthma Patients | ||||||||||||||||||
| Medical condition: The study is designed to demonstrate the robustness of the OT329 Solis product. The primary endpoint that is derived from the dataset will be product robustness after approximately 21-24 days of ... | ||||||||||||||||||
					
						
							
  | 
			||||||||||||||||||
| Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||
| Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||
| EudraCT Number: 2015-000463-13 | Sponsor Protocol Number: MGR001-1010 | Start Date*: 2015-05-05 | ||||||||||||||||
| Sponsor Name:Mylan Pharma UK Ltd | ||||||||||||||||||
| Full Title: AN OPEN STUDY TO ASSESS THE ROBUSTNESS OF THE CRC749 DEVICE BY PHARMACEUTICAL PERFORMANCE FOLLOWING TWICE DAILY DOSING OF MGR001 ADMINISTERED VIA ORAL INHALATION IN SUBJECTS WITH ASTHMA OR CHRONIC ... | ||||||||||||||||||
| Medical condition: Asthma or chronic obstructive pulmonary disease (COPD) | ||||||||||||||||||
					
						
							
  | 
			||||||||||||||||||
| Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |||||||||||||||||
| Trial protocol: GB (Completed) | ||||||||||||||||||
| Trial results: View results | ||||||||||||||||||
			Subscribe to this Search
To subscribe to the RSS feed for this search click here
			.
			This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
		
			
To subscribe to the RSS feed for this search click here
			.
			This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
		| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
    	Query did not match any studies.